Funded Health Care Startups in United States
50+ funded health care startups in united states — recent funding rounds, disclosed amounts, and headquarters. Updated weekly, free to browse.
Across these 50 U.S. health care startup rounds (most recent to least recent: 2025-11-25 back to 2025-08-27), Function Health’s disclosed $298M on 2025-11-18 is the largest amount and stands far above the rest; several other high-value rounds cluster in the $120M–$200M band (e.g., Synchron $200M on 2025-11-08, Star Therapeutics $125M on 2025-09-29, Strive Health $300M on 2025-09-14), but no other disclosed round is close to $300M. The list also concentrates in a tight geographic-staging footprint: San Francisco appears repeatedly (Intellihealth 2025-11-25 $5M; House Rx 2025-11-16 $55M; Mecha Health 2025-11-06 $4M; Daymark Health 2025-09-28 $20M), while New York shows multiple large rounds (Synchron $200M on 2025-11-08; ExaCare $30M on 2025-10-13; Neura Health $11M on 2025-10-01; Optain $26M on 2025-09-12). Stage classification is mixed: Seed rounds appear alongside Venture “Series Unknown” and several late-stage deals (e.g., VeraDermics Series C $150M on 2025-10-13; Star Therapeutics Series D $125M on 2025-09-29).
Most recent rounds
50 shownRelated listings
Frequently asked
Which disclosed round looks most like an outlier, and what does the next tier look like in comparison?
Function Health’s disclosed $298M (2025-11-18) is the largest amount in the table, materially above the next tier where multiple disclosed rounds sit well below it, such as Synchron $200M (2025-11-08) and VeraDermics $150M (2025-10-13).
Do any cities appear over-represented among these rounds, and do those cities include larger checks?
San Francisco recurs several times (Intellihealth $5M on 2025-11-25; House Rx $55M on 2025-11-16; Mecha Health $4M on 2025-11-06; Daymark Health $20M on 2025-09-28), while New York also repeats and includes larger disclosed checks like Synchron $200M on 2025-11-08 and ExaCare $30M on 2025-10-13.
How much of the list is concentrated in the most recent dates shown, and what are the temporal edges?
The rounds span 2025-11-25 back to 2025-08-27, but the top of the table is tightly packed: multiple entries land in late November 2025 (e.g., Intellihealth 2025-11-25 $5M; Ember Copilot 2025-11-23 $4M; Reimagine Care 2025-11-21 $2M). The oldest rows shown include Leal Therapeutics on 2025-08-27 ($30M) and Onrise on 2025-08-27 (amount undisclosed).
What stage mix dominates, and are late-stage rounds meaningfully present alongside early rounds?
Early-stage categories appear (Seed: Ember Copilot $4M on 2025-11-23; DifferentKind $300K on 2025-11-14; OraLiva Seed $2M on 2025-10-08; Kubanda Cryotherapy Seed $500K on 2025-09-09), while late-stage is also present with sizable disclosed checks such as Synchron Series D $200M on 2025-11-08 and Strive Health Series D $300M on 2025-09-14, plus Series C/D like VeraDermics Series C $150M (2025-10-13) and Star Therapeutics Series D $125M (2025-09-29).
Are there deal-size outliers on the low end, and how do they compare to the larger disclosed rounds?
Several small disclosed rounds sit near the bottom of the disclosed amounts, including DifferentKind $300K (2025-11-14) and Kubanda Cryotherapy $500K (2025-09-09). These are far below the largest disclosed rounds such as Function Health $298M (2025-11-18) and Strive Health $300M (2025-09-14), highlighting a wide dispersion from sub-$1M to ~$300M disclosed.
How often do “Series Unknown” and undisclosed amounts prevent precise comparability?
A number of entries either use “Venture - Series Unknown” or list the amount as undisclosed, which reduces direct comparability across size and maturity—e.g., QSimulate is Seed with an undisclosed amount (2025-11-20), MiSalud has “Venture - Series Unknown” with an undisclosed amount (2025-11-09), and Lightning Step Technologies is “Private Equity” with an undisclosed amount (2025-10-30).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.